BridgeBio Oncology Therapeutics (BBOT) Prepaid Assets (2024 - 2026)

BridgeBio Oncology Therapeutics has reported Prepaid Assets for 3 years, with the latest figure at $14.1 million in Q1 2026.

• Quarterly Prepaid Assets rose 21987.84% year-over-year to $14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.1 million (up 21987.84% YoY) and the FY2025 annual result came in at $6.6 million, up 119.72% from the prior year.
• Prepaid Assets advanced to $14.1 million in Q1 2026 per BBOT's latest filing, from $6.6 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $14.1 million in Q1 2026 and troughed at $6327.0 in Q3 2024.
• A 3-year average of $3.5 million and a median of $150048.0 in 2025 frame the typical range for Prepaid Assets.
• The widest YoY moves for Prepaid Assets: up 118423.79% in 2025, down 119.72% in 2025.
• Over 3 years, Prepaid Assets stood at $3.0 million in 2024, then jumped by 119.72% to $6.6 million in 2025, then surged by 114.98% to $14.1 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $14.1 million, $6.6 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.